The University of Connecticut School of Pharmacy Doctor of Pharmacy program has earned another extended 8-year accreditation, the longest term achievable for any college/school of pharmacy and only achievable by long established colleges/schools of pharmacy, from the Accreditation Council for Pharmacy Education (ACPE). The school’s current accreditation is valid until June 30, 2029.
The University of Connecticut School of Pharmacy’s Doctor of Pharmacy program is accredited by the Accreditation Council for Pharmacy Education, 190 South LaSalle Street, Suite 2850, Chicago, IL 60603-3499, 312/664-3575; FAX 866/228-2631, web site www.acpe-accredit.org.
Parent institution: The school’s parent institution, the University of Connecticut, is accredited by the New England Commission of Higher Education (NECHE). The university’s current accreditation is valid until fall 2026.
NECHE’s policies and regulations pertaining to the accreditation process are available on the NECHE website (neche.org) or by contacting them at 3 Burlington Woods Drive, Suite 100 Burlington, MA 01803; 781/425-7785.
On-Time Graduation Rates
| Class of 2017 | Class of 2018 | Class of 2019 | Class of 2020 | Class of 2021 | |
| Delayed for personal or academic reasons | 4 | 4 | 2 | 6 | 1 |
| Left program voluntarily, due to death, or dismissal | 1 | 2 | 2 | 5 | 10 |
| Students extending graduation date to pursue dual degree | 1 | 1 | 0 | 2 | 1 |
| On-time graduation rate | 95% | 94% | 96% | 87.21% | 88.17% |
Post-graduation employment path (students surveyed during graduation)
| 2017 102 students |
2018 97 students |
2019 93 students |
2020 73 students |
2021 76 students |
|
| Community - chain/grocery | 29 (28.4%) | 27 (27.8) | 24 (25.8%) | 9 (12.3%) | 21 (27.6%) |
| Community - independent | 1 (1%) | 1 (1%) | 1 (1%) | 3 (3.9%) | |
| Residency | 47 (46%) | 40 (41.3%) | 41 (44%) | 29 (39.7%) | 23 (30.3%) |
| Fellowship | 10 (9.8%) | 4 (4.1%) | 6 (6.5%) | 3 (4.1%) | 9 (11.8%) |
| Hospital pharmacy | 4 (4.1%) | 2 (2%) | 2 (2.7%) | 2 (2.6%) | |
| Armed Forces | 1 (1%) | 1 (1%) | |||
| LTC Pharmacy | 1 (1%) | ||||
| MPH | |||||
| Pharma Industry | 2 (2%) | 3 (3%) | 2 (2.7%) | 1 (1.3%) | |
| VA system | |||||
| Pursuing Medical School | 1 (1%) | ||||
| PhD | 2 (1.9%) | 1 (1%) | |||
| Other industry | 1 (1%) | 2 (2%) | 1(1.4%) | 2 (2.6%) | |
| Medical Marijuana Dispensary | 1 (1%) | 1 (1.4%) | 1 (1.3%) | ||
| Per diem | 1 (1%) | 1 (1%) | 1 (1%) | ||
| No information | 8 (11%) | 2 (2.6%) | |||
| Still finalizing plans | 11 (10.8%) | 12 (12.4%) | 13 (14%) | 18 (24.7%)* | 12 (15.8%) |
*COVID-19 impacted hiring at the traditional time. Graduation online.
North American Pharmacist Licensure Examination (NAPLEX) Passing Rates
| Class of '16 | Class of '17 | Class of '18 | Class of '19 | Class of '20 |
Class of '21** |
|
| First-time attempt pass rate | 91.75% | 92.55%* | 92.31%* | 89.41%* | 90.48%* | 77% |
*Compare to national averages: 2017 81.96%; 2018 83.09%; 2019 81.91%; 2020 88.43%
** Full COVID-19 impact year